metabolomics
BioMark Diagnostics Secures C$2.9M to Advance Early Cancer Detection Assays
The company will use the money to advance the development and commercialization of its liquid biopsy cancer detection panels.
Trinity Biotech to Acquire Metabolomics Dx for $1.3M in Cash and Stock
Trinity plans to bring to market in 2025 Metabolomics Diagnostics' PrePsia test that can be used to determine preeclampsia risk in the 12th week of pregnancy.
Nightingale Health Nabs Regulatory Clearances for Blood Testing in the UK, Singapore
The Finland-based firm said that its blood analysis technology can replace conventional clinical chemistry and aid the assessment of chronic disease risk.
23andMe, Nightingale Health Collaborate to Offer Blood-Based Metabolomic Testing
Under a pilot program, 23andMe will offer up to 5,000 23andMe+ Premium and Total Health members free blood testing using Nightingale's Remote Health Check panel.
Nightingale Health to Open US Lab, Provide Blood Testing Services to Weill Cornell
The firm said that the new laboratory will make its blood analysis technology available to the Englander Institute for Precision Medicine and other partners in the US.